Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Sites of first disease progression following first-line therapy for HER2-positive MBC
| Site at progressive disease, n (%) | De novo patients (n = 327) | Recurrent patients (n = 674) |
|---|---|---|
| Bone/breast only | 103 (31.5) | 174 (25.8) |
| Visceral | 73 (22.3) | 226 (33.5) |
| Any central nervous system | 57 (17.4) | 105 (15.6) |
| Node/local | 16 (4.9) | 61 (9.1) |
| Other sites | 0 (0) | 1 (0.1) |
Site of first disease progression after metastatic diagnosis HER2 human epidermal growth factor receptor 2
